Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.

Hämäläinen A, Grau-Olivares M, Tervo S, Niskanen E, Pennanen C, Huuskonen J, Kivipelto M, Hänninen T, Tapiola M, Vanhanen M, Hallikainen M, Helkala EL, Nissinen A, Vanninen RL, Soininen H.

Neurodegener Dis. 2008;5(3-4):186-9. doi: 10.1159/000113698. Epub 2008 Mar 6.

PMID:
18322386
2.

Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.

Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

J Alzheimers Dis. 2010;21(3):947-66. doi: 10.3233/JAD-2010-100201.

PMID:
20693633
3.

Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.

Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH.

Arch Neurol. 2003 Oct;60(10):1394-9.

PMID:
14568809
4.

Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment.

Thomann PA, Roth AS, Dos Santos V, Toro P, Essig M, Schröder J.

Dement Geriatr Cogn Disord. 2008;26(4):300-5. doi: 10.1159/000161054. Epub 2008 Oct 9.

PMID:
18843182
5.

Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment.

Hämäläinen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen J, Kivipelto M, Hänninen T, Tapiola M, Vanhanen M, Hallikainen M, Helkala EL, Nissinen A, Vanninen R, Soininen H.

Neuroimage. 2007 Oct 1;37(4):1122-31. Epub 2007 Jun 29.

PMID:
17683950
6.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
7.

Dementia, quantitative neuroimaging, and apolipoprotein E genotype.

Bigler ED, Lowry CM, Anderson CV, Johnson SC, Terry J, Steed M.

AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1857-68.

8.

The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.

Samaranch L, Cervantes S, Barabash A, Alonso A, Cabranes JA, Lamet I, Ancín I, Lorenzo E, Martínez-Lage P, Marcos A, Clarimón J, Alcolea D, Lleó A, Blesa R, Gómez-Isla T, Pastor P.

J Alzheimers Dis. 2010;22(4):1065-71. doi: 10.3233/JAD-2010-101011.

PMID:
20930301
9.

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.

Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.

Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29.

PMID:
18334913
10.

CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.

Herukka SK, Helisalmi S, Hallikainen M, Tervo S, Soininen H, Pirttilä T.

Neurobiol Aging. 2007 Apr;28(4):507-14. Epub 2006 Mar 20.

PMID:
16546302
11.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging.

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309
12.

The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.

Luckhaus C, Cohnen M, Flüss MO, Jänner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Mödder U, Wittsack HJ.

Psychiatry Res. 2010 Jul 30;183(1):44-51. doi: 10.1016/j.pscychresns.2010.04.003. Epub 2010 Jun 11.

PMID:
20541374
13.

[Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].

Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.

Rev Neurol. 2004 May 1-15;38(9):801-7. Spanish.

14.

Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.

Yuan Y, Zhang Z, Bai F, You J, Yu H, Shi Y, Liu W.

J Affect Disord. 2010 Mar;121(3):273-7. doi: 10.1016/j.jad.2009.07.003. Epub 2009 Jul 31.

PMID:
19647324
15.

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR.

Arch Neurol. 2008 Jan;65(1):94-100. doi: 10.1001/archneurol.2007.23.

PMID:
18195145
16.

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

Korf ES, Wahlund LO, Visser PJ, Scheltens P.

Neurology. 2004 Jul 13;63(1):94-100.

PMID:
15249617
17.

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.

Yip AG, Brayne C, Easton D, Rubinsztein DC; Medical Research Council Cognitive Function Ageing Study (MRC CFAS).

J Med Genet. 2002 Sep;39(9):639-43.

18.

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

Chételat G, Landeau B, Eustache F, Mézenge F, Viader F, de la Sayette V, Desgranges B, Baron JC.

Neuroimage. 2005 Oct 1;27(4):934-46.

PMID:
15979341
19.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
20.

Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.

Goñi J, Cervantes S, Arrondo G, Lamet I, Pastor P, Pastor MA.

J Alzheimers Dis. 2013;33(4):1009-19. doi: 10.3233/JAD-2012-121174.

PMID:
23064258

Supplemental Content

Support Center